Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
Clinical trial NCT04551430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04551430
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2027-02-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.